Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet
A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 200 participants.
Also called NCT05560204
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 200 participants
- Sponsor
- Prince of Wales Hospital, Shatin, Hong Kong
- Registry
-
NCT05560204
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Hong Kong SAR China
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT05560204. Randomized; no masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Combined Pulsed-field Ablation (PFA) and Left Atrial Appendage Occlusion Using Watchman Flx or Amulet
- Acronym
- COMPAWA
- Condition
- Combined Pulsed-field Ablation (PFA)
- Intervention (Device)
- Combined Pulsed-field Ablation (PFA) + Left Atrial Appendage Occlusion (LAAO)
- Lead sponsor
- Prince of Wales Hospital, Shatin, Hong Kong
Record details
- Record id
cardio:ct-nct05560204- Content hash
ed19d73322c06a736a6eb1a1749871e5175a9c8587c76da3337402e0f12568b6